Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2 | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

XML

Psoriatic arthritis

Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2

Online download statistics by month:

Online download statistics by month: December 2020 to May 2023

	Abstract	Full	Pdf
Dec 2020	1494	1445	813
Jan 2021	1125	1125	639
Feb 2021	1457	1449	710
Mar 2021	1356	1315	764
Apr 2021	1093	1060	585
May 2021	870	833	306
Jun 2021	826	795	401
Jul 2021	566	549	235
Aug 2021	492	485	233
Sep 2021	455	434	234
Oct 2021	530	511	280
Nov 2021	412	394	214
Dec 2021	496	487	207
Jan 2022	483	488	242
Feb 2022	485	490	267
Mar 2022	546	536	403
Apr 2022	352	344	200
May 2022	371	358	213
Jun 2022	358	354	159
Jul 2022	410	400	197
Aug 2022	435	423	147
Sep 2022	450	438	166
Oct 2022	372	341	161
Nov 2022	365	346	157
Dec 2022	199	193	96
Jan 2023	225	215	116
Feb 2023	325	309	161
Mar 2023	362	340	173
Apr 2023	347	333	126
Total	17257	16790	8605